\relax 
\providecommand\hyper@newdestlabel[2]{}
\providecommand\HyperFirstAtBeginDocument{\AtBeginDocument}
\HyperFirstAtBeginDocument{\ifx\hyper@anchor\@undefined
\global\let\oldcontentsline\contentsline
\gdef\contentsline#1#2#3#4{\oldcontentsline{#1}{#2}{#3}}
\global\let\oldnewlabel\newlabel
\gdef\newlabel#1#2{\newlabelxx{#1}#2}
\gdef\newlabelxx#1#2#3#4#5#6{\oldnewlabel{#1}{{#2}{#3}}}
\AtEndDocument{\ifx\hyper@anchor\@undefined
\let\contentsline\oldcontentsline
\let\newlabel\oldnewlabel
\fi}
\fi}
\global\let\hyper@last\relax 
\gdef\HyperFirstAtBeginDocument#1{#1}
\providecommand\HyField@AuxAddToFields[1]{}
\providecommand\HyField@AuxAddToCoFields[2]{}
\@writefile{toc}{\contentsline {chapter}{\numberline {第一章\hspace  {.3em}}研究的意义和现状}{2}{chapter.1}\protected@file@percent }
\@writefile{lof}{\addvspace {10.0pt}}
\@writefile{lot}{\addvspace {10.0pt}}
\@writefile{toc}{\contentsline {section}{\numberline {第\hspace  {0.25em plus 0.125em minus 0.08em}\ignorespaces 1\hspace  {0.25em plus 0.125em minus 0.08em}\ignorespaces 节}研究的意义}{2}{section.1.1}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {1.1}{\ignorespaces 特异性细胞免疫示意图。真实的过程比这要复杂的多。\relax }}{2}{figure.caption.2}\protected@file@percent }
\providecommand*\caption@xref[2]{\@setref\relax\@undefined{#1}}
\newlabel{Cell_Immune}{{1.1}{2}{特异性细胞免疫示意图。真实的过程比这要复杂的多。\relax }{figure.caption.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.2}{\ignorespaces 特异性体液免疫示意图。此图简要说明了体液免疫过程中，抗体的的产生和对病抗原的识别，真实的过程比这要复杂的多，比如说 T helper 的作用等。 同时，抗体除了直接杀死病原体之外，还可以参与抗体介导的细胞毒性(antibody directed cell cytotoxicity)。\relax }}{3}{figure.caption.3}\protected@file@percent }
\newlabel{SerumImmune}{{1.2}{3}{特异性体液免疫示意图。此图简要说明了体液免疫过程中，抗体的的产生和对病抗原的识别，真实的过程比这要复杂的多，比如说 T helper 的作用等。 同时，抗体除了直接杀死病原体之外，还可以参与抗体介导的细胞毒性(antibody directed cell cytotoxicity)。\relax }{figure.caption.3}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.3}{\ignorespaces 抗体结构示意图\relax }}{3}{figure.caption.4}\protected@file@percent }
\newlabel{AntibodySchematic}{{1.3}{3}{抗体结构示意图\relax }{figure.caption.4}{}}
\citation{Vaccine}
\citation{Vaccine}
\citation{HIV1-vaccine}
\citation{AntibodySociety}
\citation{Blockade}
\citation{Trend}
\@writefile{lof}{\contentsline {figure}{\numberline {1.4}{\ignorespaces 疫苗的数量变化和疫苗开发技术的发展\cite  {Vaccine}\relax }}{4}{figure.caption.5}\protected@file@percent }
\newlabel{Vaccine}{{1.4}{4}{疫苗的数量变化和疫苗开发技术的发展\cite {Vaccine}\relax }{figure.caption.5}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.5}{\ignorespaces 单克隆抗体制备示意图\relax }}{5}{figure.caption.6}\protected@file@percent }
\newlabel{MonoclonalAntibody}{{1.5}{5}{单克隆抗体制备示意图\relax }{figure.caption.6}{}}
\citation{TherapeuticPeptides}
\citation{HyHEL1}
\citation{HyHEL2}
\citation{HyHEL7}
\citation{HyHEL3}
\citation{HyHEL4}
\citation{HyHEL5}
\citation{HyHEL6}
\citation{HyHEL8}
\citation{HyHEL9}
\citation{HyHEL10}
\citation{HyHEL11}
\citation{HyHEL12}
\citation{HyHEL13}
\citation{HyHEL14}
\citation{HyHEL15}
\citation{HyHEL16}
\citation{ConformationalEpitope}
\citation{ConformationalEpitope}
\@writefile{toc}{\contentsline {section}{\numberline {第\hspace  {0.25em plus 0.125em minus 0.08em}\ignorespaces 2\hspace  {0.25em plus 0.125em minus 0.08em}\ignorespaces 节}抗原抗体相互作用研究现状}{6}{section.1.2}\protected@file@percent }
\citation{ConformationalEpitope1}
\citation{EpitopePred1}
\citation{EpitopePred2}
\citation{EpitopePred3}
\citation{SEPPA}
\citation{CEP}
\citation{DiscoTope}
\citation{PEPOP}
\citation{ElliPro}
\citation{PEPITO}
\citation{EpitopePredEvaluation}
\@writefile{lof}{\contentsline {figure}{\numberline {1.6}{\ignorespaces \textbf  {A} 是 SC1918/H1 和 CR6261 复合物的结构。\textbf  {B} 是 SC1918/H1 和抗体结合区域的放大图，其抗原表位都已经标出。此图由文献\cite  {ConformationalEpitope}中的图片编辑而成。 \relax }}{7}{figure.caption.7}\protected@file@percent }
\newlabel{ConformationalEpitope}{{1.6}{7}{\textbf {A} 是 SC1918/H1 和 CR6261 复合物的结构。\textbf {B} 是 SC1918/H1 和抗体结合区域的放大图，其抗原表位都已经标出。此图由文献\cite {ConformationalEpitope}中的图片编辑而成。 \relax }{figure.caption.7}{}}
\citation{EpitopePredNotAccurate}
\citation{ASEP}
\citation{DiscoTope}
\citation{EpiPred}
\citation{iPatch1}
\citation{iPatch2}
\citation{iPatch2}
\citation{Bepar}
\citation{AssociationRule}
\citation{PEASE}
\citation{HotSpot}
\citation{HotSpot0}
\citation{HotSpotConser}
\citation{AntibodyGenHot1}
\citation{HotSpotPred1}
\citation{HotSpotPred2}
\citation{HotSpotPred2}
\@writefile{toc}{\contentsline {section}{\numberline {第\hspace  {0.25em plus 0.125em minus 0.08em}\ignorespaces 3\hspace  {0.25em plus 0.125em minus 0.08em}\ignorespaces 节}本论文的主要内容}{14}{section.1.3}\protected@file@percent }
\citation{SAbDab}
\citation{CDRDefine1}
\@writefile{toc}{\contentsline {chapter}{\numberline {第二章\hspace  {.3em}}数据的提取和初步分析}{15}{chapter.2}\protected@file@percent }
\@writefile{lof}{\addvspace {10.0pt}}
\@writefile{lot}{\addvspace {10.0pt}}
\@writefile{toc}{\contentsline {section}{\numberline {第\hspace  {0.25em plus 0.125em minus 0.08em}\ignorespaces 1\hspace  {0.25em plus 0.125em minus 0.08em}\ignorespaces 节}数据提取}{15}{section.2.1}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {2.1}{\ignorespaces 数据提取流程\relax }}{15}{figure.caption.8}\protected@file@percent }
\newlabel{DataExtraction}{{2.1}{15}{数据提取流程\relax }{figure.caption.8}{}}
\@writefile{lot}{\contentsline {table}{\numberline {2.1}{\ignorespaces 轻链上CDR区域的确定\relax }}{16}{table.caption.9}\protected@file@percent }
\newlabel{CDRL_Range}{{2.1}{16}{轻链上CDR区域的确定\relax }{table.caption.9}{}}
\@writefile{lot}{\contentsline {table}{\numberline {2.2}{\ignorespaces 重链上CDR区域的确定\relax }}{16}{table.caption.10}\protected@file@percent }
\newlabel{CDRH_Range}{{2.2}{16}{重链上CDR区域的确定\relax }{table.caption.10}{}}
\newlabel{CN}{{2.1}{16}{数据提取}{equation.2.1.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2.2}{\ignorespaces 截断距离和聚类数之间的关系。A为 testing set 中重链的聚类情况，B 为 testing set 中轻链的聚类情况， C 为 training set 中重链的聚类情况， D 为 training set 中轻链的聚类情况。\relax }}{17}{figure.caption.11}\protected@file@percent }
\newlabel{ElbowMethod}{{2.2}{17}{截断距离和聚类数之间的关系。A为 testing set 中重链的聚类情况，B 为 testing set 中轻链的聚类情况， C 为 training set 中重链的聚类情况， D 为 training set 中轻链的聚类情况。\relax }{figure.caption.11}{}}
\@writefile{lot}{\contentsline {table}{\numberline {2.3}{\ignorespaces \small {来自于 1adq(PDB 编号) 重链和其对应抗原之间所有可能相互作用的氨基酸对。}\relax }}{18}{table.caption.12}\protected@file@percent }
\newlabel{All_Contact_aa}{{2.3}{18}{\small {来自于 1adq(PDB 编号) 重链和其对应抗原之间所有可能相互作用的氨基酸对。}\relax }{table.caption.12}{}}
\@writefile{loa}{\contentsline {algorithm}{\numberline {1}{\ignorespaces Extract contacting sequences\relax }}{19}{algorithm.1}\protected@file@percent }
\newlabel{ExtractCores}{{1}{19}{Extract contacting sequences\relax }{algorithm.1}{}}
\@writefile{toc}{\contentsline {section}{\numberline {第\hspace  {0.25em plus 0.125em minus 0.08em}\ignorespaces 2\hspace  {0.25em plus 0.125em minus 0.08em}\ignorespaces 节}数据的初步分析}{20}{section.2.2}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {2.1.}Core 的分布}{20}{subsection.2.2.1}\protected@file@percent }
\@writefile{lot}{\contentsline {table}{\numberline {2.4}{\ignorespaces \small {不同 match-type 下 Core 的数目。}\relax }}{20}{table.caption.13}\protected@file@percent }
\newlabel{Cover_over_MatchType}{{2.4}{20}{\small {不同 match-type 下 Core 的数目。}\relax }{table.caption.14}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2.3}{\ignorespaces Core 的数目按不同 match-type 的分布\relax }}{21}{figure.caption.15}\protected@file@percent }
\newlabel{F_core_match_t}{{2.3}{21}{Core 的数目按不同 match-type 的分布\relax }{figure.caption.15}{}}
\@writefile{lot}{\contentsline {table}{\numberline {2.5}{\ignorespaces \small {不同 match-type 的 Core 在不同CDR上的分布}\relax }}{21}{table.caption.16}\protected@file@percent }
\newlabel{Core_CDR}{{2.5}{21}{\small {不同 match-type 的 Core 在不同CDR上的分布}\relax }{table.caption.16}{}}
\@writefile{lot}{\contentsline {table}{\numberline {2.6}{\ignorespaces Normalize 后，不同 match-type 的 Core 在不同CDR上的分布\relax }}{21}{table.caption.17}\protected@file@percent }
\newlabel{P_value_CDR3_Domi}{{2.6}{21}{Normalize 后，不同 match-type 的 Core 在不同CDR上的分布\relax }{table.caption.17}{}}
\citation{TYR_important1}
\citation{TYR_important2}
\citation{Tyr_Ser_Gly}
\citation{Four_aa_Lib}
\citation{Four_Tyr_Dom}
\@writefile{toc}{\contentsline {subsection}{\numberline {2.2.}Core 中氨基酸的分布}{23}{subsection.2.2.2}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {2.4}{\ignorespaces 抗原氨基酸和抗体氨基酸在所有Core中的分布情况\relax }}{23}{figure.caption.18}\protected@file@percent }
\newlabel{AA_distr_all}{{2.4}{23}{抗原氨基酸和抗体氨基酸在所有Core中的分布情况\relax }{figure.caption.18}{}}
\@writefile{lot}{\contentsline {table}{\numberline {2.7}{\ignorespaces 不同 match-type 下，前五个分布频率最高的抗体氨基酸\relax }}{23}{table.caption.19}\protected@file@percent }
\newlabel{Top_5_Antibody}{{2.7}{23}{不同 match-type 下，前五个分布频率最高的抗体氨基酸\relax }{table.caption.19}{}}
\citation{Hydrophobic}
\citation{Add_water}
\@writefile{lot}{\contentsline {table}{\numberline {2.8}{\ignorespaces 不同 match-type 下，前五个分布频率最高的抗原氨基酸\relax }}{24}{table.caption.20}\protected@file@percent }
\newlabel{Top_5_Antigen}{{2.8}{24}{不同 match-type 下，前五个分布频率最高的抗原氨基酸\relax }{table.caption.20}{}}
\@writefile{lot}{\contentsline {table}{\numberline {2.9}{\ignorespaces \small {和所有抗原氨基酸相比，富集最为显著的抗原氨基酸（按照q value 排序）。}\relax }}{25}{table.caption.21}\protected@file@percent }
\newlabel{Top_5_Antigen_Q}{{2.9}{25}{\small {和所有抗原氨基酸相比，富集最为显著的抗原氨基酸（按照q value 排序）。}\relax }{table.caption.21}{}}
\@writefile{lot}{\contentsline {table}{\numberline {2.10}{\ignorespaces \small {和所有抗原氨基酸相比，稀释最为显著的抗原氨基酸（按照q value 排序）。}\relax }}{25}{table.caption.22}\protected@file@percent }
\newlabel{Bottom_5_Antigen_Q}{{2.10}{25}{\small {和所有抗原氨基酸相比，稀释最为显著的抗原氨基酸（按照q value 排序）。}\relax }{table.caption.22}{}}
\@writefile{lot}{\contentsline {table}{\numberline {2.11}{\ignorespaces \small {把抗原的中间氨基酸和所有的抗原氨基酸比较。}\relax }}{26}{table.caption.23}\protected@file@percent }
\newlabel{Top_concentrated_diluted_middle_aa}{{2.11}{26}{\small {把抗原的中间氨基酸和所有的抗原氨基酸比较。}\relax }{table.caption.24}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2.5}{\ignorespaces 中间氨基酸的组成比例\relax }}{26}{figure.caption.25}\protected@file@percent }
\newlabel{Middle_aa}{{2.5}{26}{中间氨基酸的组成比例\relax }{figure.caption.25}{}}
\citation{Quantifiable}
\citation{Quantifiable}
\@writefile{toc}{\contentsline {chapter}{\numberline {第三章\hspace  {.3em}}径向基函数网络（RBFN） 的构建}{27}{chapter.3}\protected@file@percent }
\@writefile{lof}{\addvspace {10.0pt}}
\@writefile{lot}{\addvspace {10.0pt}}
\@writefile{toc}{\contentsline {section}{\numberline {第\hspace  {0.25em plus 0.125em minus 0.08em}\ignorespaces 1\hspace  {0.25em plus 0.125em minus 0.08em}\ignorespaces 节}Core 之间距离的定义}{27}{section.3.1}\protected@file@percent }
\newlabel{sim}{{3.1}{28}{Core 之间距离的定义}{equation.3.1.1}{}}
\newlabel{positive}{{3.2}{28}{Core 之间距离的定义}{equation.3.1.2}{}}
\citation{FastCenter}
\citation{FastCenter}
\citation{FastCenter}
\@writefile{toc}{\contentsline {section}{\numberline {第\hspace  {0.25em plus 0.125em minus 0.08em}\ignorespaces 2\hspace  {0.25em plus 0.125em minus 0.08em}\ignorespaces 节}RBFN 模型}{29}{section.3.2}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {2.1.}RBFN 模型的构建}{29}{subsection.3.2.1}\protected@file@percent }
\newlabel{RBFN}{{3.5}{29}{RBFN 模型的构建}{equation.3.2.5}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.1}{\ignorespaces 文献\cite  {FastCenter}选取 center 的流程图\relax }}{29}{figure.caption.26}\protected@file@percent }
\newlabel{Coverage_Center}{{3.1}{29}{文献\cite {FastCenter}选取 center 的流程图\relax }{figure.caption.26}{}}
\citation{FastCenter}
\citation{OF_IOF}
\citation{OF_IOF}
\citation{Eskin}
\citation{BreastCancer}
\citation{FastCenter}
\citation{FastCenter}
\citation{FastCenter}
\citation{FastCenter}
\citation{FastCenter}
\@writefile{loa}{\contentsline {algorithm}{\numberline {2}{\ignorespaces Center Selection Method\relax }}{30}{algorithm.2}\protected@file@percent }
\newlabel{CenterSelectAlg}{{2}{30}{Center Selection Method\relax }{algorithm.2}{}}
\citation{Eskin}
\citation{FastCenter}
\citation{Eskin}
\citation{FastCenter}
\citation{OF_IOF}
\citation{FastCenter}
\citation{OF_IOF}
\citation{FastCenter}
\@writefile{lof}{\contentsline {figure}{\numberline {3.2}{\ignorespaces Hamming distance 的定义可以参看文献\cite  {FastCenter}。Loss Guided 表示 LGM 方法， Random Cluster 表示文献 \cite  {FastCenter} 给出的方法。\relax }}{31}{figure.caption.27}\protected@file@percent }
\newlabel{Hamming_BRE}{{3.2}{31}{Hamming distance 的定义可以参看文献\cite {FastCenter}。Loss Guided 表示 LGM 方法， Random Cluster 表示文献 \cite {FastCenter} 给出的方法。\relax }{figure.caption.27}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.3}{\ignorespaces Eskin distance 的定义可以参看文献\cite  {Eskin}。Loss Guided 表示 LGM 方法， Random Cluster 表示文献 \cite  {FastCenter} 给出的方法。\relax }}{31}{figure.caption.28}\protected@file@percent }
\newlabel{Eskin_BRE}{{3.3}{31}{Eskin distance 的定义可以参看文献\cite {Eskin}。Loss Guided 表示 LGM 方法， Random Cluster 表示文献 \cite {FastCenter} 给出的方法。\relax }{figure.caption.28}{}}
\citation{OF_IOF}
\citation{FastCenter}
\citation{OF_IOF}
\citation{FastCenter}
\citation{FastCenter}
\citation{FastCenter}
\citation{FastCenter}
\citation{FastCenter}
\citation{FastCenter}
\@writefile{lof}{\contentsline {figure}{\numberline {3.4}{\ignorespaces OF 表示 Occurence Frequency， 定义可以参看文献\cite  {OF_IOF}。Loss Guided 表示 LGM 方法， Random Cluster 表示文献 \cite  {FastCenter} 给出的方法。\relax }}{32}{figure.caption.29}\protected@file@percent }
\newlabel{OF_BRE}{{3.4}{32}{OF 表示 Occurence Frequency， 定义可以参看文献\cite {OF_IOF}。Loss Guided 表示 LGM 方法， Random Cluster 表示文献 \cite {FastCenter} 给出的方法。\relax }{figure.caption.29}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.5}{\ignorespaces IOF 表示 Inverse Occurence Frequency， 定义可以参看文献\cite  {OF_IOF}。Loss Guided 表示 LGM 方法， Random Cluster 表示文献 \cite  {FastCenter} 给出的方法。\relax }}{32}{figure.caption.30}\protected@file@percent }
\newlabel{IOF_BRE}{{3.5}{32}{IOF 表示 Inverse Occurence Frequency， 定义可以参看文献\cite {OF_IOF}。Loss Guided 表示 LGM 方法， Random Cluster 表示文献 \cite {FastCenter} 给出的方法。\relax }{figure.caption.30}{}}
\citation{BFGS}
\@writefile{lot}{\contentsline {table}{\numberline {3.1}{\ignorespaces \small {在观测值为 CN 时，在各种 match-type 下的 交叉检验的最优表现和对应超参数取值。}\relax }}{34}{table.caption.31}\protected@file@percent }
\newlabel{Best_para_Numerical}{{3.1}{34}{\small {在观测值为 CN 时，在各种 match-type 下的 交叉检验的最优表现和对应超参数取值。}\relax }{table.caption.32}{}}
\@writefile{lot}{\contentsline {table}{\numberline {3.2}{\ignorespaces \small {在观测值为 0, 1 时，在各种 match-type 下的 交叉检验的最有表现和对应超参数取值。}\relax }}{34}{table.caption.33}\protected@file@percent }
\newlabel{Best_para_Binary}{{3.2}{34}{\small {在观测值为 0, 1 时，在各种 match-type 下的 交叉检验的最有表现和对应超参数取值。}\relax }{table.caption.34}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {2.2.}RBFN 模型的检验}{35}{subsection.3.2.2}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {3.6}{\ignorespaces 在不同 match-type 下 RBFN 模型正负测试集的区分。在每种 match-type 下，有 10 条 ROC 曲线对应 10 组测试集，Average AUC 是这 10 个测试集 AUC 的平均。\relax }}{35}{figure.caption.35}\protected@file@percent }
\newlabel{Discrimination}{{3.6}{35}{在不同 match-type 下 RBFN 模型正负测试集的区分。在每种 match-type 下，有 10 条 ROC 曲线对应 10 组测试集，Average AUC 是这 10 个测试集 AUC 的平均。\relax }{figure.caption.35}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.7}{\ignorespaces 在不同 match-type 下 整合 模型正负测试集的区分。在每种 match-type 下，有 10 条 ROC 曲线对应 10 组测试集，Average AUC 是这 10 个测试集 AUC 的平均。\relax }}{37}{figure.caption.36}\protected@file@percent }
\newlabel{Integrated}{{3.7}{37}{在不同 match-type 下 整合 模型正负测试集的区分。在每种 match-type 下，有 10 条 ROC 曲线对应 10 组测试集，Average AUC 是这 10 个测试集 AUC 的平均。\relax }{figure.caption.36}{}}
\@writefile{toc}{\contentsline {chapter}{\numberline {第四章\hspace  {.3em}}RBFN 模型的应用}{38}{chapter.4}\protected@file@percent }
\@writefile{lof}{\addvspace {10.0pt}}
\@writefile{lot}{\addvspace {10.0pt}}
\@writefile{toc}{\contentsline {section}{\numberline {第\hspace  {0.25em plus 0.125em minus 0.08em}\ignorespaces 1\hspace  {0.25em plus 0.125em minus 0.08em}\ignorespaces 节}Core 中抗原氨基酸和抗体氨基酸的区分}{38}{section.4.1}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {4.1}{\ignorespaces RBFN 用来区分测试集 T 和 TR 的ROC曲线和对应 AUC 值。\relax }}{39}{figure.caption.37}\protected@file@percent }
\newlabel{reverse}{{4.1}{39}{RBFN 用来区分测试集 T 和 TR 的ROC曲线和对应 AUC 值。\relax }{figure.caption.37}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.2}{\ignorespaces 整合模型用来区分测试集 T 和 TR 的ROC曲线和对应 AUC 值。 \relax }}{40}{figure.caption.38}\protected@file@percent }
\newlabel{Integrated_Reverse}{{4.2}{40}{整合模型用来区分测试集 T 和 TR 的ROC曲线和对应 AUC 值。 \relax }{figure.caption.38}{}}
\@writefile{lot}{\contentsline {table}{\numberline {4.1}{\ignorespaces 各种情况下的AUC值\relax }}{41}{table.caption.39}\protected@file@percent }
\newlabel{AUC_Commutative}{{4.1}{41}{各种情况下的AUC值\relax }{table.caption.40}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.3}{\ignorespaces 各种情况下 AUC 的差值。0.0722 是 AUC(I,T,R) 和 AUC(R,T,R) 在各种 match-type 下差值的平均。0.1277， 0.0966， 0.0411 也做类似计算。\relax }}{41}{figure.caption.41}\protected@file@percent }
\newlabel{Commutative}{{4.3}{41}{各种情况下 AUC 的差值。0.0722 是 AUC(I,T,R) 和 AUC(R,T,R) 在各种 match-type 下差值的平均。0.1277， 0.0966， 0.0411 也做类似计算。\relax }{figure.caption.41}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.4}{\ignorespaces 对图 \ref  {Commutative} 交换关系的解释\relax }}{42}{figure.caption.42}\protected@file@percent }
\newlabel{Commutative_Explanation}{{4.4}{42}{对图 \ref {Commutative} 交换关系的解释\relax }{figure.caption.42}{}}
\citation{AffinityLimit}
\citation{AffinityMaturation}
\citation{PhageDisplay}
\citation{PhageDisplay1}
\citation{EnergyPerturb1}
\citation{EnergyPerturb2}
\citation{Insilico1}
\citation{Lippow}
\citation{AB-Bind}
\citation{STATIUM}
\citation{AB-Bind}
\@writefile{toc}{\contentsline {section}{\numberline {第\hspace  {0.25em plus 0.125em minus 0.08em}\ignorespaces 2\hspace  {0.25em plus 0.125em minus 0.08em}\ignorespaces 节}预测突变对抗原抗体复合物亲和力的影响}{43}{section.4.2}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {2.1.}可预测氨基酸对的提取}{44}{subsection.4.2.1}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {4.5}{\ignorespaces 相互作用突变氨基酸对的提取。\relax }}{44}{figure.caption.43}\protected@file@percent }
\newlabel{ContactingPairs}{{4.5}{44}{相互作用突变氨基酸对的提取。\relax }{figure.caption.43}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.6}{\ignorespaces 把突变氨基酸对的抗体氨基酸限定在 CDR 上。\relax }}{45}{figure.caption.44}\protected@file@percent }
\newlabel{Predictable}{{4.6}{45}{把突变氨基酸对的抗体氨基酸限定在 CDR 上。\relax }{figure.caption.44}{}}
\citation{AB-Bind}
\citation{AB-Bind}
\@writefile{toc}{\contentsline {subsection}{\numberline {2.2.}亲和力变化的预测}{46}{subsection.4.2.2}\protected@file@percent }
\@writefile{lot}{\contentsline {table}{\numberline {4.2}{\ignorespaces \small {$\Delta \Delta G$ 位于不同范围的突变复合物的亲和力的预测效果。}\relax }}{46}{table.caption.46}\protected@file@percent }
\newlabel{Affinity_Pred}{{\caption@xref {Affinity_Pred}{ on input line 1118}}{46}{亲和力变化的预测}{table.caption.46}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.7}{\ignorespaces 各种方法的预测效果。CN：是本文的方法, Contacting Number 首字母缩写。其他方法请参考文献 \cite  {AB-Bind}。突变体复合物的选择是在 one\_WithinRang\_True 的类型下。$\Delta \Delta G$ 的单位是 KJ/mol 。\relax }}{47}{figure.caption.47}\protected@file@percent }
\newlabel{Affinity_Predict}{{4.7}{47}{各种方法的预测效果。CN：是本文的方法, Contacting Number 首字母缩写。其他方法请参考文献 \cite {AB-Bind}。突变体复合物的选择是在 one\_WithinRang\_True 的类型下。$\Delta \Delta G$ 的单位是 KJ/mol 。\relax }{figure.caption.47}{}}
\@writefile{lot}{\contentsline {table}{\numberline {4.3}{\ignorespaces \small {Bootstrap 方法构建各种不同方法 AUC 95\% 的置信区间。}\relax }}{48}{table.caption.48}\protected@file@percent }
\newlabel{Bootstrap}{{4.3}{48}{\small {Bootstrap 方法构建各种不同方法 AUC 95\% 的置信区间。}\relax }{table.caption.49}{}}
\citation{rASA1}
\citation{rASA2}
\citation{FastCenter}
\citation{FastCenter}
\@writefile{toc}{\contentsline {chapter}{\numberline {第五章\hspace  {.3em}}讨论}{49}{chapter.5}\protected@file@percent }
\@writefile{lof}{\addvspace {10.0pt}}
\@writefile{lot}{\addvspace {10.0pt}}
\bibcite{Vaccine}{1}
\bibcite{HIV1-vaccine}{2}
\bibcite{AntibodySociety}{3}
\bibcite{Blockade}{4}
\bibcite{Trend}{5}
\bibcite{TherapeuticPeptides}{6}
\bibcite{HyHEL1}{7}
\bibcite{HyHEL2}{8}
\bibcite{HyHEL7}{9}
\bibcite{HyHEL3}{10}
\bibcite{HyHEL4}{11}
\bibcite{HyHEL5}{12}
\bibcite{HyHEL6}{13}
\bibcite{HyHEL8}{14}
\bibcite{HyHEL9}{15}
\bibcite{HyHEL10}{16}
\bibcite{HyHEL11}{17}
\bibcite{HyHEL12}{18}
\bibcite{HyHEL13}{19}
\bibcite{HyHEL14}{20}
\bibcite{HyHEL15}{21}
\bibcite{HyHEL16}{22}
\bibcite{ConformationalEpitope}{23}
\bibcite{ConformationalEpitope1}{24}
\bibcite{EpitopePred1}{25}
\bibcite{EpitopePred2}{26}
\bibcite{EpitopePred3}{27}
\bibcite{EpitopePred4}{28}
\bibcite{SEPPA}{29}
\bibcite{CEP}{30}
\bibcite{DiscoTope}{31}
\bibcite{PEPOP}{32}
\bibcite{ElliPro}{33}
\bibcite{PEPITO}{34}
\bibcite{EpitopePredEvaluation}{35}
\bibcite{EpitopePredNotAccurate}{36}
\bibcite{ASEP}{37}
\bibcite{EpiPred}{38}
\bibcite{PEASE}{39}
\bibcite{EpiPred}{40}
\bibcite{iPatch1}{41}
\bibcite{iPatch2}{42}
\bibcite{Bepar}{43}
\bibcite{AssociationRule}{44}
\bibcite{HotSpot}{45}
\bibcite{HotSpot0}{46}
\bibcite{HotSpotConser}{47}
\bibcite{AntibodyGenHot1}{48}
\bibcite{HotSpotPred1}{49}
\bibcite{HotSpotPred2}{50}
\bibcite{AffinityLimit}{51}
\bibcite{AffinityMaturation}{52}
\bibcite{PhageDisplay}{53}
\bibcite{PhageDisplay1}{54}
\bibcite{EnergyPerturb1}{55}
\bibcite{EnergyPerturb2}{56}
\bibcite{Insilico1}{57}
\bibcite{Lippow}{58}
\bibcite{AB-Bind}{59}
\bibcite{STATIUM}{60}
\bibcite{SAbDab}{61}
\bibcite{CDRDefine1}{62}
\bibcite{TYR_important1}{63}
\bibcite{TYR_important2}{64}
\bibcite{Tyr_Ser_Gly}{65}
\bibcite{Four_aa_Lib}{66}
\bibcite{Four_Tyr_Dom}{67}
\bibcite{Hydrophobic}{68}
\bibcite{Add_water}{69}
\bibcite{Quantifiable}{70}
\bibcite{FastCenter}{71}
\bibcite{BFGS}{72}
\bibcite{Sub_Mat1}{73}
\bibcite{Sub_Mat2}{74}
\bibcite{Sub_Mat3}{75}
\bibcite{Sub_Mat4}{76}
\bibcite{BreastCancer}{77}
\bibcite{OF_IOF}{78}
\bibcite{Eskin}{79}
\bibcite{rASA1}{80}
\bibcite{rASA2}{81}
